Pain Control After Arthroscopic Shoulder Surgeries

Post Operative Pain Clinical Trial

Official title:

Comparative Study of Analgesic Efficacy of Ultrasound Guided Interscalene Block Versus Combined Shoulder Anterior Capsular Block and Suprascapular Nerve Block for Arthroscopic Shoulder Surgeries.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05686395
• Other study ID #: IRB0010038
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2023
• Est. completion date: January 2024

Study information

• Verified date: January 2023
• Source: Tanta University
• Contact: HOSAMELDIN ELDIB, MASTER
• Phone: 00201000504087
• Email: dr.semsem337[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will be conducted to compare the perioperative analgesic efficacy of ultrasound - guided interscalene brachial plexus block versus combined shoulder anterior capsular block and anterior suprascapular nerve block for arthroscopic shoulder surgeries.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 90
• Est. completion date: January 2024
• Est. primary completion date: August 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 65 Years

Eligibility

Inclusion Criteria:

• Patients aged 20-65 years of both sexes, with American Society of Anesthesiologists (ASA) physical status I or II admitted for arthroscopic shoulder surgery.

Exclusion Criteria:

• Patient refusal.
• Uncooperative patient.
• Patient with neurological deficit.
• Patients with respiratory disorders.
• Patient with bleeding disorders.
• Infection at the block injection site.
• Patients with history of allergy to local anesthetics.

Related Conditions & MeSH terms

• Pain, Postoperative
• Post Operative Pain

Intervention

Procedure:
• Ultrasound-guided Interscalene Block group
ultrasound guided interscalene block versus combined ultrasound guided shoulder anterior capsular block and suprascapular nerve block for arthroscopic shoulder surgery
• Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block
Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block

Drug:
• Bupivacaine
bupivacaine 0.25%.

Locations

Country	Name	City	State
Egypt	Faculty of Medicine Tanta University	Tanta

Sponsors (1)

Lead Sponsor	Collaborator
Tanta University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	post operative analgesic consumption	The first 24 hours post operative analgesic consumption	24 hours after surgery
Secondary	Visual Analogue score (VAS) in the first 24 hours after surgery	- Postoperative pain intensity will be assessed in the first 24 hour using VAS score where (0 = no pain and 100 = the worst imaginable pain)	first 24 hours after surgery
Secondary	Patient satisfaction score	Patient satisfaction score will be assessed on the basis of a questionnaire and graded on a 4-point scale (excellent/good/fair/poor).	first 24 hours after surgery
Secondary	The incidence of hemi diaphragmatic paralysis	hemidiaphragmatic paralysis after block	immediately before block and immediately after procedure